Biogen Inc

NAS : BIIB

$232.65+1.76%

Financials

Balance sheet · full history

USD in millions · per-share amounts unscaled. Each period shows the value from the latest filing that prints it.

Reported line item	Dec 31, 2018Balance date	Dec 31, 2019Balance date	Dec 31, 2020Balance date	Dec 31, 2021Balance date	Dec 31, 2022Balance date	Dec 31, 2023Balance date	Dec 31, 2024Balance date	Dec 31, 2025Balance date

Balance sheet, full reported history for 0000875045. USD in millions · per-share amounts unscaled. Each period shows the value from the latest filing that prints it.
Reported line item	Dec 31, 2018	Dec 31, 2019	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025
Cash and cash equivalents	1,224.6	2,913.7	1,331.2	2,261.4	3,419.3	1,049.9	2,375	3,008.5
Current portion of marketable securities							0	807.2
Marketable securitiesno longer reported	2,313.4	1,562.2	1,278.9	1,541.1	1,473.5	0
Accounts receivable, net of allowance for doubtful accounts of $3.0 and $2.2, respectively	1,958.5	1,880.5	1,913.8	1,549.4	1,705	1,664.1	1,404.8	1,342.4
Due from anti-CD20 therapeutic programs	526.9	590.2	413.5	412.3	431.4	435.9	464	524.6
Inventory	929.9	804.2	1,068.6	1,351.5	1,344.4	2,527.4	2,460.5	2,168.1
Other current assets	687.6	631	881.1	740.8	1,417.6	1,182	752.5	1,123.3
Total current assets	7,640.9	8,381.8	6,887.1	7,856.5	9,791.2	6,859.3	7,456.8	8,974.1
Marketable securities	1,375.9	1,408.1	772.1	892	705.7	0	0	431.9
Property, plant and equipment, net	3,601.2	3,247.3	3,411.5	3,416.4	3,298.6	3,309.7	3,181.3	3,055.4
Operating lease assets	0	427	433.3	375.4	403.9	420	356.4	265.4
Intangible assets, net	3,120	3,527.4	3,084.3	2,221.3	1,850.1	8,363	9,691.2	9,178.5
Goodwill	5,706.4	5,757.8	5,762.1	5,761.1	5,749	6,219.2	6,478.9	6,491.1
Deferred tax asset	2,153.9	3,232.1	1,369.5	1,415.1	1,226.4	928.6	324.2	292.5
Investments and other assets	1,690.6	1,252.8	2,899	1,939.5	1,529.2	745	560.5	750.6
Total assets	25,288.9	27,234.3	24,618.9	23,877.3	24,554.1	26,844.8	28,049.3	29,439.5
Current portion of notes payable	0	1,495.8	0	999.1	0	150	1,748.6	0
Taxes payable	63.5	71.4	142	174.7	259.9	257.4	548.3	114.8
Accounts payable	370.5	530.8	454.9	589.2	491.5	403.3	424.2	432
Accrued expense and other	2,861.2	2,765.8	3,145.3	2,535.2	2,521.4	2,623.6	2,807.7	2,802.6
Total current liabilities	3,295.2	4,863.8	3,742.2	4,298.2	3,272.8	3,434.3	5,528.8	3,349.4
Notes payable					6,281	6,788.2	4,547.2	6,286.8
Notes payableno longer reported	5,936.5	4,459	7,426.2	6,274	6,281
Deferred tax liability	1,636.2	2,810.8	1,032.8	694.5	334.7	641.8	190.5	507.6
Long-term operating lease liabilities	0	412.7	402	330.4	333	400	334.5	290.4
Other long-term liabilities	1,389.4	1,348.9	1,329.6	1,320.5	944.2	781.1	732.3	748.5
Total liabilities	12,257.3	13,895.2	13,932.8	12,917.6	11,165.7	12,045.4	11,333.3	11,182.7
Commitments, contingencies and guarantees (Notes 22 and 23)	—	—	—	—	—	—	—	—
Preferred stock, par value $0.001 per share					0	0	0	0
Preferred stock, par value $0.001 per shareno longer reported	0	0	0	0	0
Common stock, par value $0.0005 per share					0.1	0.1	0.1	0.1
Common stock, par value $0.0005 per shareno longer reported	0.1	0.1	0.1	0.1	0.1
Additional paid-in capital	0	0	0	68.2	73.3	302.5	569.4	863.1
Accumulated other comprehensive income (loss)	(240.4)	(135.2)	(299)	(106.7)	(164.9)	(153.7)	(136.2)	(182)
Retained earnings	16,257	16,455.4	13,976.3	13,911.7	16,466.5	17,627.6	19,259.8	20,552.7
Treasury stock, at cost; 23.8 million and 23.8 million shares, respectively	(2,977.1)	(2,977.1)	(2,977.1)	(2,977.1)	(2,977.1)	(2,977.1)	(2,977.1)	(2,977.1)
Total equity	13,031.6	13,339.1	10,686.1	10,959.7	13,388.4	14,799.4	16,716	18,256.8
Total Biogen Inc. shareholders equityno longer reported	13,039.6	13,343.2	10,700.3	10,896.2	13,397.9	14,799.4
Total liabilities and equity	25,288.9	27,234.3	24,618.9	23,877.3	24,554.1	26,844.8	28,049.3	29,439.5
Noncontrolling interestsno longer reported	(8)	(4.1)	(14.2)	63.5	(9.5)	0

History starts FY2018, the period ended Dec 31, 2018 — the earliest period our structured-data source covers, not the company’s first year.

40 reported lines · 8 periods · values taken from the latest filing that prints each period.

italic7 from an earlier filing than the rest of the column.
no longer reported6 lines the filer stopped printing.
— the filer printed the line and left the period empty. An empty cell means the line was not printed at all; it is never a zero.

279 of 279 values link to the exact element in the filer’s own document.

Every line and every caption is the company’s own. Each period carries the value from the latest filing that prints it, which is why a restated period shows the restated number with the figure as first reported kept underneath.

Nothing on this table is computed by us: no fourth quarter, no growth rate, no margin. Marks describe the filer’s own restatements.